Immunohistochemistry (IHC) for IDH1 was performed on 19 patients (61%), reporting positive results in 4/10 glioblastomas (40%), 3/4 anaplastic astrocytoma (75%), and in 5/5 oligodendroglial tumors (100%). This evidence concerns the gene IDH1 and glioblastoma.